Japan· JP-2290704G1024

ドルナーゼ　アルファ（遺伝子組換え）

A medicinal product containing ドルナーゼアルファ（遺伝子組換え）, registered in Japan by 中外製薬, on the national reimbursement list.

On Japan’s NHI price list

Checked against MHLW / PMDA (Japan) on September 25, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about ドルナーゼアルファ（遺伝子組換え）Answers with sources · free account Check interactionsSeverity free · mechanism on Growth

The record

At a glance

MHLW / PMDA (Japan)

Active substance: ドルナーゼアルファ（遺伝子組換え）
Manufacturer: 中外製薬
Country: Japan (JP)
ATC code: —
Reimbursed: Yes
Source register: MHLW / PMDA (Japan)
Last checked: September 25, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

ドルナーゼアルファ（遺伝子組換え） in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ドルナーゼアルファ（遺伝子組換え） products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

Austria · Pulmozyme
Belgium · Pulmozyme
Bulgaria · Пулмозим
Cyprus · Pulmozyme
Czechia · Pulmozyme
Germany · Pulmozyme
Denmark · Pulmozyme
Estonia · Pulmozyme
Spain · Pulmozyme
Finland · Pulmozyme
France · Pulmozyme
United Kingdom (Northern Ireland) · Pulmozyme
Greece · Pulmozyme
Croatia · Pulmozyme Otopina Za Atomizator
Hungary · Pulmozyme
Ireland · Pulmozyme
Iceland · Pulmozyme
Italy · Pulmozyme
Lithuania · Pulmozyme
Luxembourg · Pulmozyme
Latvia · Pulmozyme
Netherlands · Pulmozyme Verneveloplossing
Norway · Pulmozyme
Poland · Pulmozyme
Portugal · Pulmozyme
Romania · Pulmozyme
Sweden · Pulmozyme
Slovenia · Pulmozyme
Slovakia · Pulmozyme

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/ea6063b9-d25a-4e71-bce6-afdb82badc5f
GET /v1/drugs/ea6063b9-d25a-4e71-bce6-afdb82badc5f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "spec": "２．５ｍｇ２．５ｍＬ１管",
  "marks": null,
  "source": "mhlw",
  "remarks": null,
  "yj_code": "2290704G1024",
  "category": "外用薬",
  "price_yen": 6982.1,
  "generic_name": "ドルナーゼ　アルファ（遺伝子組換え）",
  "product_name_jp": null,
  "therapeutic_class": "2290",
  "transitional_expiry": null
}

API reference MCP server Plans

See everything about ドルナーゼアルファ（遺伝子組換え）.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console

ドルナーゼ アルファ（遺伝子組換え）